Coverage

More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3%…

In his latest column, KFF President and CEO Drew Altman explains why Medicaid, despite former President Donald Trump’s silence on the topic, warrants greater attention given the potential for drastic changes or cuts to it should Republicans win control in the election.

KFF is tracking the Medicaid provisions in the 2025 federal budget bill, including new Medicaid work and verification requirements and a reduction in the expansion match rate for states that use their own funds to cover undocumented immigrants.

In his Beyond the Data column, KFF President and CEO Drew Altman discusses how how family health coverage is no longer affordable for workers at small employers, contributing to the health cost crisis affecting the American people.